Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes

Int J Mol Sci. 2023 Jul 27;24(15):12010. doi: 10.3390/ijms241512010.

Abstract

Topoisomerases, common targets for anti-cancer therapeutics, are crucial enzymes for DNA replication, transcription, and many other aspects of DNA metabolism. The potential anti-cancer effects of thiosemicarbazones (TSC) and metal-TSC complexes have been demonstrated to target several biological processes, including DNA metabolism. Human topoisomerases were discovered among the molecular targets for TSCs, and metal-chelated TSCs specifically displayed significant inhibition of topoisomerase II. The processes by which metal-TSCs or TSCs inhibit topoisomerases are still being studied. In this brief review, we summarize the TSCs and metal-TSCs that inhibit various types of human topoisomerases, and we note some of the key unanswered questions regarding this interesting class of diverse compounds.

Keywords: antitumor; bis-thiosemicarbazone; thiosemicarbazone; topoisomerase.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Coordination Complexes* / pharmacology
  • Copper / pharmacology
  • DNA
  • DNA Topoisomerases, Type II / metabolism
  • Humans
  • Thiosemicarbazones* / pharmacology

Substances

  • Coordination Complexes
  • DNA Topoisomerases, Type II
  • Copper
  • DNA
  • Thiosemicarbazones
  • Antineoplastic Agents

Grants and funding

This research received no external funding.